# Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

> **NCT00198510** · PHASE3 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 750 (—)

## Conditions studied

- Vitreous Hemorrhage
- Diabetic Retinopathy

## Interventions

- **DRUG:** Vitrase
- **DRUG:** Vitrase
- **DRUG:** Vitrase

## Key facts

- **NCT ID:** NCT00198510
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-11
- **Primary completion:** 2001-09
- **Final completion:** 2003-03
- **Target enrollment:** 750 (—)
- **Last updated:** 2013-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198510, "Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00198510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*